These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26562312)

  • 1. Search for an Endogenous Bombesin-Like Receptor 3 (BRS-3) Ligand Using Parabiotic Mice.
    Lateef DM; Xiao C; Reitman ML
    PLoS One; 2015; 10(11):e0142637. PubMed ID: 26562312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bombesin-like receptor 3 (Brs3) expression in glutamatergic, but not GABAergic, neurons is required for regulation of energy metabolism.
    Xiao C; Piñol RA; Carlin JL; Li C; Deng C; Gavrilova O; Reitman ML
    Mol Metab; 2017 Nov; 6(11):1540-1550. PubMed ID: 29107299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRS3 in both MC4R- and SIM1-expressing neurons regulates energy homeostasis in mice.
    Xiao C; Liu N; Province H; Piñol RA; Gavrilova O; Reitman ML
    Mol Metab; 2020 Jun; 36():100969. PubMed ID: 32229422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity.
    Guan XM; Chen H; Dobbelaar PH; Dong Y; Fong TM; Gagen K; Gorski J; He S; Howard AD; Jian T; Jiang M; Kan Y; Kelly TM; Kosinski J; Lin LS; Liu J; Marsh DJ; Metzger JM; Miller R; Nargund RP; Palyha O; Shearman L; Shen Z; Stearns R; Strack AM; Stribling S; Tang YS; Wang SP; White A; Yu H; Reitman ML
    Cell Metab; 2010 Feb; 11(2):101-12. PubMed ID: 20096642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of body temperature and brown adipose tissue thermogenesis by bombesin receptor subtype-3.
    Lateef DM; Abreu-Vieira G; Xiao C; Reitman ML
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E681-7. PubMed ID: 24452453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism.
    Lateef DM; Xiao C; Brychta RJ; Diedrich A; Schnermann J; Reitman ML
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H891-8. PubMed ID: 26801314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
    Ladenheim EE; Hamilton NL; Behles RR; Bi S; Hampton LL; Battey JF; Moran TH
    Endocrinology; 2008 Mar; 149(3):971-8. PubMed ID: 18039774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reanalysis of parabiosis of obesity mutants in the age of leptin.
    Zeng W; Lu YH; Lee J; Friedman JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3874-82. PubMed ID: 26150485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parabiosis between db/db and ob/ob or db/+ mice.
    Harris RB
    Endocrinology; 1999 Jan; 140(1):138-45. PubMed ID: 9886818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals.
    Tang H; Shu C; Chen H; Zhang X; Zang Z; Deng C
    PLoS Biol; 2019 Mar; 17(3):e3000175. PubMed ID: 30840614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and pharmacology of bombesin receptor subtype-3.
    Majumdar ID; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female mice target deleted for the neuromedin B receptor have partial resistance to diet-induced obesity.
    Paula GS; Souza LL; Cabanelas A; Bloise FF; Mello-Coelho V; Wada E; Ortiga-Carvalho TM; Oliveira KJ; Pazos-Moura CC
    J Physiol; 2010 May; 588(Pt 9):1635-45. PubMed ID: 20211980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.
    Ohki-Hamazaki H; Watase K; Yamamoto K; Ogura H; Yamano M; Yamada K; Maeno H; Imaki J; Kikuyama S; Wada E; Wada K
    Nature; 1997 Nov; 390(6656):165-9. PubMed ID: 9367152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
    Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML
    Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E816-24. PubMed ID: 20807840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evidence for unidentified leptin-induced circulating factors that control white fat mass.
    Harris RB
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1499-511. PubMed ID: 26468261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hervey, Harris, and the parabiotic search for lipostatic signals.
    Smith GP
    Appetite; 2013 Feb; 61(1):97-9. PubMed ID: 22983368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
    Guan XM; Metzger JM; Yang L; Raustad KA; Wang SP; Spann SK; Kosinski JA; Yu H; Shearman LP; Faidley TD; Palyha O; Kan Y; Kelly TM; Sebhat I; Lin LS; Dragovic J; Lyons KA; Craw S; Nargund RP; Marsh DJ; Strack AM; Reitman ML
    J Pharmacol Exp Ther; 2011 Feb; 336(2):356-64. PubMed ID: 21036912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bombesin-Like Receptor 3: Physiology of a Functional Orphan.
    Xiao C; Reitman ML
    Trends Endocrinol Metab; 2016 Sep; 27(9):603-605. PubMed ID: 27055378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity.
    Phan LK; Chung WK; Leibel RL
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E611-20. PubMed ID: 16638826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.